Home / Share Price Target / Pplpharma
Piramal Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Piramal Pharma Limited | |||
 | Symbol: PPLPHARMA | ||
| Price: ₹258.45 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Piramal Pharma Brief Company Overview
- 1.1: Piramal Pharma Limited: A Comprehensive Overview
- 1.1.1: Piramal Pharma Limited
- 1.2: Piramal Pharma Financial Performance
- 1.2.1: Is Piramal Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Piramal Pharma Share Price Target For 2024
- 2.1.1: Piramal Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Piramal Pharma Share Price Prediction For 2024
- 2.2: Piramal Pharma Share Price Target For 2025
- 2.2.1: Piramal Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Piramal Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Piramal Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Piramal Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Piramal Pharma Past Performance
Piramal Pharma Brief Company Overview
Piramal Pharma Limited: A Comprehensive Overview
Piramal Pharma Limited
- Piramal Pharma Limited, a subsidiary of Piramal Enterprises Limited, is a leading pharmaceutical company incorporated in 2020 and based in Mumbai, India.
- The company boasts a diverse portfolio of pharmaceutical products, including injections and HPAPIs.
- Piramal Pharma Limited is renowned for its commitment to providing high-quality pharma services and upholding industry standards.
Advertisement
Piramal Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 19,750.53 Crore | Market valuation of Piramal Pharma's shares. |
| Revenue (TTM) | 8,171.16 Crore | Total revenue generated by Piramal Pharma over the past twelve months. |
| Net Income (TTM) | +17.82 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 13.07% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 0.21% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +14.7% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +102.1% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 59.53 | Company's total debt divided by total shareholder equity. |
| Total Debt | 4,710.15 Crore | Sum of Piramal Pharma's current & long-term financial obligations. |
| Total Cash | 627.25 Crore | Total amount of liquid funds available to Piramal Pharma. |
Is Piramal Pharma A Good Buy For Long Term?
Piramal Pharma's recent financial performance indicates strong growth potential. Its revenue surge of 14.7% and net income expansion of 102.1% in the past quarter reflect a positive trend. The company's stable profit margin of 0.21% and improved cash flow position further enhance its investment appeal. While it does carry a substantial debt of 4,710.15 Crore, this is offset by its strong revenue generation and healthy cash reserves. Overall, Piramal Pharma presents a compelling opportunity for long-term investors seeking growth and potential value appreciation.
To predict the Piramal Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Piramal Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Piramal Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Piramal Pharma shares in 2024, see the table below.
Advertisement
Piramal Pharma Share Price Target Table For 2024
| Piramal Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 268.79 (+4%) | Price Action: 05 Nov 2024 Low |
| 2024 Target 2 | 264.95 (+2.51%) | Custom Fibonacci Extension Lvl 50% |
| 2024 Target 1 | 261.52 (+1.18%) | Custom Fibonacci Extension Lvl 23.6% |
| Current Price | 258.45 | Piramal Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 257.51 (-0.37%) | Price Action: Chart |
| Stop Loss 2 | 254.91 (-1.37%) | Price Action: 30 Oct 2024 High |
| Stop Loss 3 | 251.69 (-2.62%) | Price Action: 25 Oct 2024 High |
Summary: Piramal Pharma Share Price Prediction For 2024
In summary, Piramal Pharma has surged by ₹119.60, achieving a notable +86.14% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Piramal Pharma for 2024 predicts an additional rise of 1.18% to 4% by the end of 2024 with three potential targets T1: 261.52, T2: 264.95, T3: 268.79. Stop Loss at SL1: 257.51, SL2: 254.91, SL3: 251.69.
Piramal Pharma has a 52-week high of ₹307.89, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹114.35, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Piramal Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Piramal Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Piramal Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Piramal Pharma shares in 2025, see the table below.
Advertisement
Piramal Pharma Share Price Target Table For 2025
| Piramal Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 385.84 (+49.28%) | Price Action: Chart |
| 2025 Target 2 | 378.65 (+46.5%) | Price Action: Chart |
| 2025 Target 1 | 374.90 (+45.05%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 258.45 | Piramal Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 229.75 (-11.11%) | Price Action: Sep 2024 High |
| Stop Loss 2 | 227.41 (-12.02%) | Price Action: 22 Oct 2024 High |
| Stop Loss 3 | 224.82 (-13.02%) | Price Action: 14 Oct 2024 High |
Summary: Piramal Pharma Share Price Prediction For 2025
In summary, Piramal Pharma has surged by ₹119.60, achieving a notable +86.14% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Piramal Pharma for 2025 predicts an additional rise of 45.05% to 49.28% by the end of 2025 with three potential targets T1: 374.90, T2: 378.65, T3: 385.84. Stop Loss at SL1: 229.75, SL2: 227.41, SL3: 224.82.
Piramal Pharma has a All-Time high of ₹303.00, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹114.35, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Piramal Pharma, we have created a specific page for that check here: Piramal Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Piramal Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Piramal Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 18.38% over the next 15 years.
For complete year by year Piramal Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Piramal Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Piramal Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹258.45 | [Current Price] |
| 2024 | ₹262.38 | 1.52% |
| 2025 | ₹477.1 | 81.83% |
| 2026 | ₹647.41 | 35.69% |
| 2027 | ₹763.21 | 17.88% |
| 2028 | ₹916.1 | 20.03% |
| 2029 | ₹1,094.51 | 19.47% |
| 2030 | ₹1,402.94 | 28.17% |
| 2031 | ₹1,552.48 | 10.65% |
| 2032 | ₹1,597.03 | 2.86% |
| 2033 | ₹1,737.48 | 8.79% |
| 2034 | ₹1,926.64 | 10.88% |
| 2035 | ₹2,328.78 | 20.87% |
| 2036 | ₹2,457.54 | 5.52% |
| 2037 | ₹2,430.85 | -1.09% |
| 2038 | ₹2,558.87 | 5.26% |
| 2039 | ₹2,783.62 | 8.78% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Piramal Pharma Past Performance
- In 2022, Piramal Pharma opening price was ₹200
- As of Thu 14 Nov 2024 the price stands at ₹258.45.
- This represents a Compound Annual Growth Rate (CAGR) of 8.92%.
- In 2 years, an investment of 10,000 would have become ₹12,922.5.
As we wrap up, we hope you like our study on Piramal Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
- Piramal Pharma Share Price History
- Piramal Pharma Price Target Tomorrow
- Piramal Pharma Dividend History
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
